Milestones

History

Overview
Milestones
Awards & Grants

At MicroPort® we are proud of our achievements and success. Since 1998 there have been many challenges but also many moments of triumph. Below, is a selection of the most significant events in our company's history. From our humble beginnings to the construction of our new industrial complex, it's a story driven by entrpenurial spirit and determination.

2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998

	MPSC was listed in the Shenzhen-Hong Kong Stock Connect
	"New Technology and Clinical Application of Minimally Invasive Cardiac Surgery" Project Won the Second Prize of State Science and Technology Progress Award

	"Key technology and industrialization platform for minimally invasive interventional and implantable medical devices" project won prestigious class II prize of State Science and Technology Advancement Award
	MicroPort® EP Columbus® 3D EP Navigation System received the CFDA registration certificate
	MicroPort® Online network service platform "Life Line Live" was officially launched
	MicroPort® was awarded Five Star Credit Enterprise

	Firehawk™ Rapamycin Target Eluting Coronary Stent received CE Mark certificate
	WILLIS™ clinical application project won prestigious class II prize of State Science and Technology Advancement Award
	EVOLUTION™ medial-pivot knee system received CFDA approval
	MicroPort Sorin CRM (Shanghai) Co., Ltd. launched China's first domestic pacemaker production line
	Shanghai MicroPort Orthopedics Co., Ltd. moved to new headquarters in Suzhou
	MicroPort Suzhou OrthoRecon Co., Ltd. and MicroPort Suzhou Orthopedic Instruments Co., Ltd. were established in Suzhou Industrial Zone
	MicroPort Surgical Robotics Co., Ltd. and MicroPort Online Co., Ltd. were established
	Liangzhi Creative Center and Knowledge & Action Center at corporate HQ were officially put into use
	Shanghai MicroPort EP MedTech Co., Ltd. successfully completed restructuring
	Shanghai MicroPort EP MedTech Co., Ltd. received "Shanghai Hi-Tech Enterprise" honor

	Signed joint venture agreement with Sorin Group for China's cardiac rhythm management business
	Completed acquisition of Wright Medical's OrthoRecon business
	Acquired drug eluting stent related assets and intellectual properties from Cordis
	Firehawk™ rapamycin target eluting coronary stent system received CFDA approval
	Corporate headquarters relocated to 1601 Zhangdong Rd at completed industrialization base in Zhangjiang Riverfront harbor
	Established MPSC Research & Engineering Academy

	WILLIS™ intracranial stent graft system received SFDA approval
	Construction began on Suzhou orthopedic industrial base
	Acquired Wright Medical's OrthoRecon Business for $290 Million
	Shanghai MicroPort EP MedTech Co., Ltd.'s FireMagic™, EasyFinder™, EasyLoop™ and FireMagic™ 3D and Columbus™ received CE mark certificates

	Initiated "United Fleets of MicroPort®" operating model
	Shanghai D-Pulse Medical Co., Ltd. was established in Shanghai International Medical Zone
	Shanghai MicroPort NeuroTech Co., Ltd. and MicroPort Surgical (Shanghai) Co., Ltd. were established in Shanghai International Medical Zone
	Total tax contribution reached 1 billion RMB
	Acquired D-Pulse Medical (Beijing) Co., Ltd. and Dongguan Kewei Medical Instrument Co., Ltd.
	MicroPort Orthopedics (Suzhou) Co., Ltd. was established in Suzhou Industrial Park
	MicroPort Medical (Shanghai) Co., Ltd. was renamed Shanghai MicroPort Medical (Group) Co., Ltd.
	MicroPort International Corp. Ltd. was established in Hong Kong

	Shanghai MicroPort Orthopedics Co., Ltd. acquired Suzhou Best Co., Ltd.
	Coronary drug eluting stent implants reached over 700,000 units
	Undertook national R&D projects accumulating to more than 100 million RMB
	MicroPort Medical (Jiaxing) Co., Ltd. was established in Jiaxing Science City

	Shanghai MicroPort EP MedTech Co., Ltd. was established in Shanghai International Medical Zone
	MicroPort Scientific Corporation listed on Hong Kong Stock Exchange (00853.HK)
	Annual sales exceeded 100 million USD

	Shanghai MicroPort Orthopedics Co., Ltd. was established in Shanghai International Medical Zone
	FireMagic™ ablation catheter received SFDA approval
	Construction of a new industrialization base began in Zhangjiang Riverfront Harbor
	Received 54.3 million RMB from Shanghai municipal government to develop and enhance industrial capacity in minimally invasive medicine

	Shanghai MicroPort Lifesciences Co, Ltd. was established at the Shanghai International Medical Zone
	Officially entered diabetes business with acquisition of Beijing PanGeRui Medical Device Company
	Firebird2™ coronary drug eluting stent system received SFDA approval
	Began experimental implementation of "Vertical Integration & Horizontal Connection" management concept

Firebird™ coronary drug eluting stent system won prestigious class II prize of State Science and Technology Advancement Award

	Coronary drug eluting stent implants reached over 100,000 units
	MicroPort Scientific Corporation was established
	Entered Latin American market with successful auditing by ANMAT of Argentina

	Firebird™ drug eluting stent system was named Shanghai's key new product
	Annual sales exceeded 100 million RMB

	Firebird™ drug eluting stent system received SFDA approval
	Mustang™ coronary stent system received CE mark certificate

Officially entered international market with PTCA Balloon dilatation catheters by receiving import license from Ministry of Health, Labor and Welfare of Japan

Received major funding from National Development and Reform Commission

	Moved into new headquarters at 501 Newton Road, Zhangjiang Hi-Tech Park
	Received "Shanghai Hi-Tech Enterprise" honor and business became profitable

Mustang™ bare metal stent received SFDA approval

PTCA balloon dilatation catheter received SFDA approval, very first sale made

Founded on May 15, 1998 at an incubation center in Zhangjiang Hi-Tech Park, Shanghai

Next : Awards & Grants